Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Orchard Therapeutics
Orchard Therapeutics
(ORTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Atidarsagene autotemcel
metachromatic leukodystrophy
,
lysosomal storage diseases
Antithrombin iii
anemia
,
iron-deficiency anemia
,
iron deficiencies
,
deficiency diseases
,
chronic renal insufficiency
,
kidney diseases
Simoladagene autotemcel
severe combined immunodeficiency
,
immunologic deficiency syndromes
Arm1
heart failure
,
iron-deficiency anemia
,
iron deficiencies
Arm2
fertilization in vitro
,
rheumatoid arthritis
,
arthritis
,
prostatic hyperplasia
,
hyperplasia
,
contraception
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis seasonal
,
asthma
,
schizophrenia
,
psychotic disorders
,
bipolar disorder
,
allergic rhinitis perennial
,
metabolic syndrome
,
syndrome
,
hyperlipidemias
,
familial combined hyperlipidemia
,
breast neoplasms
,
hypercholesterolemia
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
chronic urticaria
,
urticaria
,
cardiovascular diseases
,
heart diseases
,
atherosclerosis
,
psoriasis
,
systemic lupus erythematosus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use